International Journal of Obesity, Год журнала: 2025, Номер unknown
Опубликована: Апрель 16, 2025
Язык: Английский
International Journal of Obesity, Год журнала: 2025, Номер unknown
Опубликована: Апрель 16, 2025
Язык: Английский
Опубликована: Янв. 31, 2025
Язык: Английский
Процитировано
0Опубликована: Янв. 31, 2025
Язык: Английский
Процитировано
0Опубликована: Янв. 31, 2025
Процитировано
0Diabetes Research and Clinical Practice, Год журнала: 2025, Номер 221, С. 112039 - 112039
Опубликована: Фев. 7, 2025
Endocrinologists, nephrologists, and cardiologists care for people with type 2 diabetes (T2D) coexisting cardiovascular disease (CVD), heart failure (HF), and/or chronic kidney (CKD). Glucagon-like peptide-1 receptor agonists (GLP-1RA) sodium-glucose cotransporter inhibitors (SGLT2i) should be preferentially used, but are underutilized. We examine patient physician factors associated GLP-1RA/SGLT2i use by patients treated these subspecialists. Retrospective cohort study using linked 2022 Medicare American Board of Internal Medicine data adults >65 years T2D CVD, HF, CKD their treating endocrinologists, cardiologists. identified 246,106/254,425/435,773 5,661/8,233/10,874 endocrinologists/nephrologists/cardiologists in 2022. Overall, 73.2 % endocrinologist-treated filled medications prescribed endocrinologists; 41.9 GLP-1RA/SGLT2i. Patients nephrologists were rarely subspecialists (9.8 6.1 %, respectively); however, conditional on filling any medication, they more likely to fill a (59.5 48.2 respectively). Older endocrinologists older cardiologists, less Many, particularly older, be, not, GLP-1RA/SGTL2i. Physician training may improve statistics.
Язык: Английский
Процитировано
0The Lancet Diabetes & Endocrinology, Год журнала: 2025, Номер unknown
Опубликована: Фев. 1, 2025
Язык: Английский
Процитировано
0Endocrinology Diabetes & Metabolism, Год журнала: 2025, Номер 8(2)
Опубликована: Фев. 19, 2025
ABSTRACT Aims Self‐management education is recognised as an essential element of comprehensive diabetes care. This study aims to assess the impact DESMOND (Diabetes Education and Self‐Management for Ongoing Newly Diagnosed) structured self‐management programme administered by a registered dietitian in primary‐care setting on key clinical indicators (HbA1c, weight BMI) participants who returned locally developed 6‐month follow‐up session. Methods A retrospective analysis was conducted attended 6‐h during 2018 Midwest Ireland. Paired sample t‐tests McNemar chi‐square tests were used any differences between baseline 6 months post‐intervention. Results There 66 participants, mean age 63 years. At follow‐up, HbA1c reduced 6.45 mmol/mol (standard deviation (SD): 15.02 mmol/mol, p = 0.006). The number below 53 cut‐off increased from 52% at 71% ( < 0.001). reduction 1.4 kg (SD: 4.4 kg, 0.21) found follow‐up. Those overweight BMI category decreased 30.2% 26.4%, clinically significant result. Conclusion Better glycaemic control improvements seen among program supports emerging evidence effectiveness Further research required determine optimal contact time frequency sessions order sustain observed improvement outcomes.
Язык: Английский
Процитировано
0European Geriatric Medicine, Год журнала: 2025, Номер unknown
Опубликована: Фев. 27, 2025
This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability health status. The primary research questions are: How can frailty assessment be effectively integrated into care? What strategies optimize glycaemic control outcomes for adults? innovative tools technologies, including artificial intelligence (AI), improve management this population? uses 5 I's framework (Identification, Innovation, Individualization, Integration, Intelligence) integrate care, proposing such as tools, novel therapies, digital AI systems. It also examines metabolic heterogeneity, highlighting anorexic-malnourished sarcopenic-obese phenotypes. proposed highlights importance tailoring targets levels, prioritizing quality life, minimizing treatment burden. Strategies leveraging are emphasized their potential enhance personalized care. distinct needs two phenotypes outlined, specific recommendations each group. calls holistic, patient-centered approach care ensuring equity access innovations life. need fill evidence gaps, refine healthcare integration better vulnerable
Язык: Английский
Процитировано
0Nursing and Health Sciences, Год журнала: 2025, Номер 27(1)
Опубликована: Март 1, 2025
The study explored the challenges and needs in diabetes care for people with comorbid cognitive impairment from triangular perspectives of educators, patients, family caregivers. employed a phenomenological research design qualitative data collection, involving semi-structured interviews 8 7 6 were gathered health education center hospital Taiwan. Thematic analysis was utilized to analyze data. Three categories eight themes emerged. Challenges included "care compliance", "limited involvement", "caregiver distress". Needs identified as "training educators on impairments", education", "standard procedures". Clinical realities showed "inconsistent awareness" "lack consensus resource referrals among professionals". Diabetes faces including poor compliance limited cooperation, requiring better comorbidity training caregivers, standardized procedures healthcare professionals. Findings can guide future programs serve
Язык: Английский
Процитировано
0Diabetes Research and Clinical Practice, Год журнала: 2025, Номер unknown, С. 112119 - 112119
Опубликована: Март 1, 2025
The STOP study is a proof-of-concept, aimed at evaluating the effectiveness and safety of IdegLira in deintensifying diabetes therapy elderly insulin-treated persons with T2DM. was real world, single center retrospective observation. 96 were enrolled (46F, age 77 ± 7 yrs, HbA1C 7.5 1.0, duration 21 10 yrs; 75 % basal/bolus insulin therapy). After 6 months (T6), fasting plasma glucose significantly decreased as compared to T0, did HbA1C. switch associated lower rates level 1 (L1) hypoglycemia T3 (IR 0.24, 95 CI 0.11-0.58, p < 0.001) T6 0.08, 0.02-0.34, T0. Level 2 (L2) 0.04, 0.01-0.32, proportion (incidence) L1 from 33.7 T0 17.4 (p = 0.004) 5.8 0.001). Incidence L2 22.1 1.16 No patients had T6. Rapid acting interrupted 85 patients. represents viable option an population.
Язык: Английский
Процитировано
0Phytomedicine, Год журнала: 2025, Номер unknown, С. 156758 - 156758
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0